11.05.21
Study confirms some cancer immunotherapies may lead to myocarditis and other potentially serious arrhythmias
Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis. ICI-induced myocarditis represents a new clinical syndrome because of the novelty and considerable usage of ICIs. While it has been hard to fully define the clinical features of ICI-myocarditis, new research provides a